Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?

Cawood, T J; Hunt, P J; O'Shea, D; Cole, D; Soule, S

Cawood, T J; Hunt, P J; O'Shea, D; Cole, D; Soule, S.

Affiliation

Cawood TJ; Department of Endocrinology, Christchurch Hospital, Private Bag 4710, Christchurch, New Zealand. tom.cawood@cdhb.govt.nz

Eur J Endocrinol ; 161(4): 513-27, 2009 Oct.

Article in En | MEDLINE | ID: mdl-19439510

Subject(s)

Adrenal Gland Neoplasms/diagnosis; Adrenal Gland Neoplasms/economics; Adrenal Gland Neoplasms/diagnostic imaging; Adrenal Gland Neoplasms/epidemiology; Cell Transformation, Neoplastic; Cushing Syndrome/pathology; Disease Progression; False Positive Reactions; Follow-Up Studies; Guidelines as Topic; Humans; Hyperaldosteronism/diagnosis; Pheochromocytoma/diagnosis; Radiography/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adrenal Gland Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2009 Type: Article Affiliation country: New Zealand

Fulltext

XML

PubMed Links

Search on Google